ストックスクリーナーアプリを入手
1.46
4.29%
0.06
アフターアワーズ：
1.46
前日終値:
$1.40
開ける：
$1.32
24時間の取引高:
58,649
Relative Volume:
0.15
時価総額：
$53.87M
収益：
-
当期純損益:
-
株価収益率:
-0.5794
EPS:
-2.5197
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.01%
1か月 パフォーマンス:
+44.55%
6か月 パフォーマンス:
-2.67%
1年 パフォーマンス:
-25.13%
1日の値動き範囲:
$1.32
$1.47
1週間の範囲:
$1.32
$1.53
52週間の値動き範囲:
$0.8786
$2.75
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
ANL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANL
Adlai Nortye Ltd Adr
|
1.46 | 51.66M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-02 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-09-04 | 開始されました | H.C. Wainwright | Buy |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
Adlai Nortye Ltd Adr (ANL) 最新ニュース
Adlai Nortye narrows first-half 2025 loss as oncology pipeline advances - MSN
Adlai Nortye Ltd. Shareholders Approve Redomiciliation to Singapore - MSN
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Xoma (XOMA) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Why Fonar Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket - Benzinga
Adlai Nortye Ltd ADR (ANL-Q) Stock Price and News - The Globe and Mail
Adlai Nortye licenses cancer drug to ASK Pharm in $230 million deal By Investing.com - Investing.com South Africa
Adlai Nortye shares soar on $230 million licensing deal with ASK Pharm By Investing.com - Investing.com South Africa
Adlai Nortye shares soar on $230 million licensing deal with ASK Pharm - Investing.com India
Adlai Nortye Licenses Pan-RAS Inhibitor AN9025 to ASK Pharm for Greater China - TipRanks
Adlai Nortye licenses cancer drug to ASK Pharm in $230 million deal - Investing.com
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China - Sahm
Adlai Nortye licenses pan-RAS inhibitor AN9025 to ASK Pharm for Greater China - MSN
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Update - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading 1% HigherWhat's Next? - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading 1% Higher – What’s Next? - Defense World
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Regeneron (REGN) - The Globe and Mail
Adlai Nortye Ltd. Sponsored ADR Cash Flow – LS:A3EEED - TradingView — Track All Markets
Total common shares outstanding of Adlai Nortye Ltd. Sponsored ADR – LS:A3EEED - TradingView — Track All Markets
Analysts Offer Insights on Healthcare Companies: Rigel (RIGL), Terns Pharmaceuticals (TERN) and Pyxis Oncology (PYXS) - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Adicet Bio (ACET), Palvella Therapeutics (PVLA) - The Globe and Mail
Adlai Nortye (NASDAQ:ANL) Shares Down 1.4% – Here’s Why - Defense World
Adlai Nortye (NASDAQ:ANL) Shares Down 1.4%Here's Why - MarketBeat
Adlai Nortye to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Vera Therapeutics (VERA) and Varex Imaging (VREX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Lexicon Pharmaceuticals (LXRX) and Cullinan Management (CGEM) - The Globe and Mail
H.C. Wainwright Reaffirms Their Hold Rating on Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Adlai Nortye Ltd. Plans Redomiciliation to Singapore - MSN
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Up 92.3% in September - MarketBeat
HC Wainwright Comments on Adlai Nortye FY2025 Earnings - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading Down 3.1%Here's Why - MarketBeat
GASFRAC Energy Services (OTCMKTS:GSFVF) Shares Cross Above 200 Day Moving Average – What’s Next? - Defense World
Chart based analysis of Adlai Nortye Ltd. Depositary Receipt trendsQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com
Can technical indicators confirm LZ Technology Holdings Limited’s reversalMarket Weekly Review & AI Powered Market Entry Ideas - newser.com
How to monitor COHU with trend dashboards2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Can machine learning forecast Ubiquiti Inc. recoveryQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Top chart patterns to watch in ECARX Holdings Inc. Equity WarrantWeekly Trade Summary & Technical Pattern Based Signals - newser.com
Analysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS), AnaptysBio (ANAB) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Visual analytics tools that track Adlai Nortye Ltd. Depositary Receipt performanceMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Does PBHC show high probability of reboundJuly 2025 Recap & AI Powered Buy and Sell Recommendations - newser.com
Risk vs reward if holding onto Penns Woods Bancorp Inc.2025 Key Highlights & Smart Money Movement Alerts - newser.com
Is MSBI trending in predictive chart modelsQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Short Interest in Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Declines By 65.7% - MarketBeat
Does Bentley Systems Incorporated qualify in momentum factor screening2025 Key Highlights & Consistent Return Investment Signals - newser.com
Earnings visualization tools for WSO.BJuly 2025 Market Mood & Safe Entry Trade Reports - newser.com
Earnings visualization tools for DBRG.PRJQuarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Large Decrease in Short Interest - Defense World
Analysts Set Teradata Corporation (NYSE:TDC) PT at $26.86 - Defense World
Kairos Pharma (KAPA) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Large Increase in Short Interest - MarketBeat
What machine learning models say about Adlai Nortye Ltd. Depositary ReceiptTrade Performance Summary & Verified Chart Pattern Trade Signals - Newser
Using portfolio simulators with Novo Nordisk A s (b Shares) Adrhedged includedJuly 2025 Selloffs & Trade Opportunity Analysis Reports - Newser
Adlai Nortye Ltd Adr (ANL) 財務データ
Adlai Nortye Ltd Adr (ANL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):